As a result, additional research into miRNA-induced ABCB1 or ABCG2 expression, which results in ovarian cancer drug resistance, will aid in our knowledge of the mechanism of drug resistance of ABC transporters [52]. The gene discussed is ABCB1; the disease is ovarian carcinoma.